Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Papillary renal cell carcinoma: A review of the current therapeutic landscape.

Critical reviews in oncology/hematology - 1 Oct 2015

Courthod Giulia, Tucci Marcello, Di Maio Massimo, Scagliotti Giorgio V

Abstract excerpt

Renal cell carcinoma (RCC) is the most common cancer of the kidney and accounts for 2-3% of all adult malignancies. Clear cell carcinoma represents the most common histologic subtype, while papillary Renal Cell Carcinoma (pRCC) accounts for 10-20% of all renal cell cancers. While the inactivation of VHL gene can be found in the majority of clear cell carcinomas, different molecular mechanisms are involved into...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anilides
Share to Carcinoma, Papillary
Share to Carcinoma, Renal Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oncogenes

Share to Programmed Cell Death 1 Receptor

Share to Proto-Oncogene Proteins c-met

Share to Pyrrolidinones

Share to Quinolines

Source

Identifiers

PMID: 26052049
DOI: 10.1016/j.critrevonc.2015.05.008

Genes

MET
VHL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Papillary renal cell carcinoma: A review of the current therapeutic landscape.PMID 26052049Read ↗

Papillary renal cell carcinoma: current progress and future directions.Semantic proximity Read ↗

Advanced papillary renal cell carcinoma: Epidemiology, genomic drivers, current therapies, and ongoing trials.Semantic proximity Read ↗

Genetic Alterations in Renal Cancers: Identification of The Mechanisms Underlying Cancer Initiation and Progression and of Therapeutic TargetsSemantic proximity Read ↗

Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art.Semantic proximity Read ↗

Recent progress in non-clear cell renal cell carcinoma: biology and therapeutic strategiesSemantic proximity Read ↗

Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features.Semantic proximity Read ↗

Oncotargets in Different Renal Cancer SubtypesSemantic proximity Read ↗

Current updates and future perspectives on the management of renal cell carcinoma.Semantic proximity Read ↗

[Pathological characteristics and genetic background of renal cell carcinoma].Semantic proximity Read ↗

Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the LiteratureSemantic proximity Read ↗

Molecular biology of renal cell carcinoma.Semantic proximity Read ↗

Molecular basis for the treatment of renal cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.